Healthcare · Drug Manufacturers General · NASDAQ
| Market cap | $221.79B |
|---|---|
| Trailing P/E | 18.3 |
| FCF yield | 3.6% |
| Revenue growth (YoY) | +9.9% |
| EPS growth (YoY) | +10.2% |
| FCF/share growth (YoY) | -22.2% |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
Amgen Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| David J. Taylor | House | Sell | $1,001 - $15,000 | Sep 5, 2026 |
| Sheldon Whitehouse | Senate | Sell | $1,001 - $15,000 | Sep 2, 2026 |
| Thomas H Tuberville | Senate | Sell | $15,001 - $50,000 | Aug 5, 2026 |
| Thomas H Tuberville | Senate | Sell | $15,001 - $50,000 | Aug 5, 2026 |
| Alan Armstrong | Senate | Sell | $15,001 - $50,000 | Jul 21, 2026 |
| Alan Armstrong | Senate | Sell | $15,001 - $50,000 | Jul 21, 2026 |
| Maria Elvira Salazar | House | Sell | $15,001 - $50,000 | May 8, 2026 |
| Maria Elvira Salazar | House | Buy | $15,001 - $50,000 | Apr 21, 2026 |
| David J. Taylor | House | Sell | $1,001 - $15,000 | Feb 2, 2026 |
| Julia Letlow | House | Sell | $1,001 - $15,000 | Jan 13, 2026 |
| David J. Taylor | House | Sell | $1,001 - $15,000 | Dec 5, 2025 |
| Lisa McClain | House | Sell | $1,001 - $15,000 | Oct 22, 2025 |